8-K Announcements
6Material company update
Apr 22, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Feb 6, 2026·SEC
Molina Healthcare, Inc.(MOH)Earnings, Financials & Key Ratios
MOH•NYSE•Insurance & Managed Care
$197.44
$10.28B mkt cap·22.1× P/E·Price updated May 6, 2026
AboutMolina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.Show more
- Revenue$45.43B+11.7%
- Combined Ratio98.28%+2.6%
- Net Income$472M-60.0%
- Return on Equity11.02%-59.3%
- Medical Cost Ratio91.03%+3.0%
- Operating Margin1.72%-59.1%
- Net Margin1.04%-64.2%
- ROA3.03%-60.8%
- Equity / Assets26.14%-9.1%
- Book Value per Share80.11+2.8%
- Tangible BV/Share36.89-16.8%
- Debt/Equity0.97+40.0%
MOH Key Insights
Molina Healthcare, Inc. (MOH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 22.8%
- ✓Share count reduced 12.0% through buybacks
✗Weaknesses
- ✗High loss ratio of 91.0%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
MOH Price & Volume
Molina Healthcare, Inc. (MOH) stock price & volume — 10-year historical chart
Loading chart...
MOH Growth Metrics
Molina Healthcare, Inc. (MOH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.43%
5 Years18.52%
3 Years12.42%
TTM7.66%
Profit CAGR
10 Years12.68%
5 Years-6.85%
3 Years-15.85%
TTM-84.01%
EPS CAGR
10 Years13.21%
5 Years-4.52%
3 Years-12.99%
TTM-83.71%
Return on Capital
10 Years19.2%
5 Years20.46%
3 Years19.75%
Last Year9.81%
MOH Recent Earnings
Molina Healthcare, Inc. (MOH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 22, 2026EPS
$2.35
Est $1.57
+49.7%
Revenue
$10.8B
Est $10.9B
-0.7%
Q1 2026
Feb 5, 2026EPS
$2.75
Est $0.43
-739.5%
Revenue
$11.4B
Est $10.9B
+4.6%
Q4 2025
Oct 22, 2025EPS
$1.84
Est $3.97
-53.7%
Revenue
$11.5B
Est $11.3B
+1.7%
Q3 2025
Jul 23, 2025EPS
$5.48
Est $5.62
-2.5%
Revenue
$11.4B
Est $11.0B
+4.3%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $2.35vs $1.57+49.7% | $10.8Bvs $10.9B-0.7% |
| Q1 2026 | Feb 5, 2026 | $2.75vs $0.43-739.5% | $11.4Bvs $10.9B+4.6% |
| Q4 2025 | Oct 22, 2025 | $1.84vs $3.97-53.7% | $11.5Bvs $11.3B+1.7% |
| Q3 2025 | Jul 23, 2025 | $5.48vs $5.62-2.5% | $11.4Bvs $11.0B+4.3% |
Based on last 12 quarters of dataView full earnings history →
MOH Peer Comparison
Molina Healthcare, Inc. (MOH) competitors in Government Program Managed Care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CNC | 27.31B | 55.32 | -4.06 | 19.44% | -3.25% | -28.6% | 0.94 | |
 ALHC | 3.71B | 18.14 | -4902.70 | 46.06% | 0.47% | 11.5% | 1.89 | |
 UNH | 333.37B | 367.28 | 27.76 | 11.81% | 2.68% | 11.54% | 0.77 | |
 CVS | 111.32B | 86.86 | 62.49 | 7.85% | 0.72% | 3.86% | 1.24 | |
 ELV | 81.37B | 374.71 | 14.92 | 12.62% | 2.62% | 11.92% | 0.75 | |
 HUM | 29.57B | 246.33 | 25.03 | 10.06% | 0.82% | 6.17% | 0.73 | |
 CI | 74.35B | 281.98 | 12.72 | 11.26% | 2.26% | 15.08% | 0.75 | |
 OSCR | 5.14B | 19.84 | -11.74 | 27.5% | -0.3% | -3.26% | 0.44 |
Compare MOH vs Peers
Molina Healthcare, Inc. (MOH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MOH Income Statement
Molina Healthcare, Inc. (MOH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.88B | 18.89B | 16.83B | 19.42B | 27.77B | 31.97B | 34.07B | 40.65B | 45.43B | 45.08B |
| Revenue Growth % | 12.26% | -4.99% | -10.91% | 15.41% | 42.98% | 15.13% | 6.56% | 19.31% | 11.75% | 7.66% |
| Medical Costs & Claims | 18B | 16.27B | 14.39B | 16.75B | 24.49B | 28.05B | 29.74B | 35.91B | 41.35B | 40.75B |
| Medical Cost Ratio % | 90.54% | 86.11% | 85.53% | 86.22% | 88.19% | 87.72% | 87.28% | 88.35% | 91.03% | 90.41% |
| Gross Profit | 1.88B▲ 0% | 2.62B▲ 39.6% | 2.44B▼ 7.2% | 2.68B▲ 9.9% | 3.28B▲ 22.5% | 3.93B▲ 19.7% | 4.33B▲ 10.4% | 4.74B▲ 9.3% | 4.08B▼ 14.0% | 4.32B▲ 0% |
| Gross Margin % | 9.46% | 13.89% | 14.47% | 13.78% | 11.81% | 12.28% | 12.72% | 11.65% | 8.97% | 9.59% |
| Gross Profit Growth % | 6.21% | 39.57% | -7.2% | 9.94% | 22.53% | 19.7% | 10.39% | 9.28% | -13.96% | - |
| Operating Expenses | 19.95B | 17.01B | 1.39B | 1.6B | 2.26B | 2.75B | 2.76B | 3.03B | 3.29B | 3.8B |
| OpEx / Revenue % | 100.32% | 90.06% | 8.23% | 8.23% | 8.14% | 8.61% | 8.1% | 7.45% | 7.25% | 8.42% |
| Depreciation & Amortization | 178M | 127M | 89M | 88M | 131M | 176M | 171M | 186M | 195M | 186M |
| Combined Ratio % | 190.86% | 176.17% | 93.76% | 94.45% | 96.33% | 96.33% | 95.38% | 95.8% | 98.28% | 98.84% |
| Operating Income | -555M▲ 0% | 1.13B▲ 303.8% | 1.04B▼ 7.7% | 1.08B▲ 3.3% | 1.02B▼ 5.4% | 1.17B▲ 15.0% | 1.57B▲ 34.1% | 1.71B▲ 8.5% | 781M▼ 54.2% | 524M▲ 0% |
| Operating Margin % | -2.79% | 5.99% | 6.2% | 5.55% | 3.67% | 3.67% | 4.62% | 4.2% | 1.72% | 1.16% |
| Operating Income Growth % | -281.37% | 303.78% | -7.69% | 3.26% | -5.38% | 15% | 34.1% | 8.52% | -54.25% | - |
| EBITDA | -377M | 1.26B | 1.13B | 1.17B | 1.15B | 1.35B | 1.74B | 1.89B | 976M | 710M |
| EBITDA Margin % | -1.9% | 6.66% | 6.73% | 6% | 4.14% | 4.22% | 5.12% | 4.66% | 2.15% | 1.58% |
| Interest Expense | 118M | 115M | 87M | 102M | 120M | 110M | 109M | 118M | 192M | 203M |
| Non-Operating Income | -61M | 17M | -15M | 15M | 25M | 0 | 0 | 0 | 0 | 93M |
| Pretax Income | -612M▲ 0% | 999M▲ 263.2% | 972M▼ 2.7% | 961M▼ 1.1% | 875M▼ 8.9% | 1.06B▲ 21.5% | 1.46B▲ 37.7% | 1.59B▲ 8.5% | 589M▼ 62.9% | 228M▲ 0% |
| Pretax Margin % | -3.08% | 5.29% | 5.78% | 4.95% | 3.15% | 3.32% | 4.3% | 3.91% | 1.3% | 0.51% |
| Income Tax | -100M | 292M | 235M | 288M | 216M | 271M | 373M | 410M | 117M | 40M |
| Effective Tax Rate % | 16.34% | 29.23% | 24.18% | 29.97% | 24.69% | 25.49% | 25.48% | 25.8% | 19.86% | 17.54% |
| Net Income | -512M▲ 0% | 707M▲ 238.1% | 737M▲ 4.2% | 673M▼ 8.7% | 659M▼ 2.1% | 792M▲ 20.2% | 1.09B▲ 37.8% | 1.18B▲ 8.1% | 472M▼ 60.0% | 188M▲ 0% |
| Net Margin % | -2.58% | 3.74% | 4.38% | 3.46% | 2.37% | 2.48% | 3.2% | 2.9% | 1.04% | 0.42% |
| Net Income Growth % | -6500% | 238.09% | 4.24% | -8.68% | -2.08% | 20.18% | 37.75% | 8.07% | -59.97% | -84.01% |
| EPS (Diluted) | -9.14▲ 0% | 10.55▲ 215.4% | 11.48▲ 8.8% | 11.24▼ 2.1% | 11.25▲ 0.1% | 13.54▲ 20.4% | 18.78▲ 38.7% | 20.42▲ 8.7% | 8.92▼ 56.3% | 3.69▲ 0% |
| EPS Growth % | -1093.48% | 215.43% | 8.82% | -2.09% | 0.09% | 20.36% | 38.7% | 8.73% | -56.32% | -83.71% |
| EPS (Basic) | -9.14 | 10.61 | 11.85 | 11.41 | 11.40 | 13.70 | 18.71 | 20.52 | 8.93 | - |
| Diluted Shares Outstanding | 56M | 67M | 64.2M | 59.9M | 58.6M | 58.5M | 58.1M | 57.7M | 50.79M | 51M |
MOH Balance Sheet
Molina Healthcare, Inc. (MOH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 8.47B | 7.15B | 6.79B | 9.53B | 12.21B | 12.31B | 14.89B | 15.63B | 15.56B | 16.39B |
| Asset Growth % | 13.72% | -15.55% | -5.13% | 40.45% | 28.08% | 0.86% | 20.94% | 4.96% | -0.42% | 5.97% |
| Total Investment Assets | 2.64B | 1.8B | 2.02B | 1.88B | 3.2B | 3.5B | 4.26B | 4.33B | 0 | 2M |
| Long-Term Investments | 119M | 120M | 79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 2.52B | 1.68B | 1.95B | 1.88B | 3.2B | 3.5B | 4.26B | 4.33B | 0 | 0 |
| Total Current Assets | 7.51B | 6.46B | 5.97B | 7.88B | 10.06B | 10.08B | 12.54B | 12.77B | 12.44B | 13.33B |
| Cash & Equivalents | 3.19B | 2.83B | 2.45B | 4.15B | 4.44B | 4.01B | 4.85B | 4.66B | 4.25B | 5.31B |
| Receivables | 871M | 1.33B | 1.41B | 1.67B | 2.18B | 2.3B | 3.1B | 3.3B | 3.53B | 14.33B |
| Other Current Assets | 691M | 476M | 0 | 0 | 0 | 277M | 331M | 487M | 4.66B | 4.59B |
| Goodwill & Intangibles | 255M | 190M | 172M | 941M | 1.25B | 1.39B | 1.45B | 1.94B | 2.19B | 8.66B |
| Goodwill | 186M | 143M | 143M | 692M | 982M | 1.11B | 1.24B | 1.67B | 2.19B | 2.09B |
| Intangible Assets | 69M | 47M | 29M | 249M | 270M | 275M | 208M | 267M | 0 | 0 |
| PP&E (Net) | 342M | 241M | 385M | 391M | 396M | 259M | 270M | 288M | 301M | 300M |
| Other Assets | 141M | 24M | 105M | 255M | 391M | 361M | 404M | 424M | 446M | 458M |
| Total Liabilities | 7.13B | 5.51B | 4.83B | 7.44B | 9.58B | 9.35B | 10.68B | 11.13B | 11.49B | 12.31B |
| Total Debt | 2.17B | 1.46B | 1.49B | 2.35B | 2.39B | 2.39B | 2.38B | 3.12B | 3.95B | 3.95B |
| Net Debt | -1.02B | -1.37B | -966M | -1.8B | -2.05B | -1.61B | -2.46B | -1.54B | -298M | -1.37B |
| Long-Term Debt | 1.32B | 1.02B | 1.24B | 2.13B | 2.17B | 2.18B | 2.18B | 2.92B | 3.77B | 3.95B |
| Short-Term Debt | 652M | 240M | 18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 5.56B | 4.25B | 3.27B | 4.96B | 7.05B | 6.86B | 8.17B | 7.9B | 7.37B | 8.19B |
| Accounts Payable | 366M | 390M | 502M | 641M | 842M | 889M | 1.25B | 1.33B | 0 | 0 |
| Deferred Revenue | 282M | 211M | 249M | 375M | 370M | 359M | 418M | 51M | 0 | 401M |
| Other Current Liabilities | 522M | 476M | -18M | 0 | 0 | 0 | 0 | 0 | 7.37B | 7.79B |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 61M | 44M | 90M | 119M | 140M | 104M | 124M | 120M | 173M | 176M |
| Total Equity | 1.34B▲ 0% | 1.65B▲ 23.2% | 1.96B▲ 19.0% | 2.1B▲ 6.9% | 2.63B▲ 25.5% | 2.96B▲ 12.7% | 4.21B▲ 42.2% | 4.5B▲ 6.7% | 4.07B▼ 9.5% | 4.08B▲ 0% |
| Equity Growth % | -18.92% | 23.19% | 19% | 6.94% | 25.48% | 12.7% | 42.21% | 6.67% | -9.5% | -31.93% |
| Shareholders Equity | 1.34B | 1.65B | 1.96B | 2.1B | 2.63B | 2.96B | 4.21B | 4.5B | 4.07B | 4.08B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 298M | 1.01B | 1.78B | 1.86B | 2.4B | 2.8B | 3.89B | 4.09B | 3.6B | 3.62B |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5M | -8M | 4M | 37M | -5M | -160M | -82M | -57M | 15M | -7M |
| Return on Equity (ROE) | -34.29% | 47.39% | 40.87% | 33.19% | 27.89% | 28.32% | 30.39% | 27.07% | 11.02% | 4.44% |
| Return on Assets (ROA) | -6.43% | 9.05% | 10.57% | 8.25% | 6.06% | 6.46% | 8.02% | 7.73% | 3.03% | 1.18% |
| Equity / Assets | 15.78% | 23.02% | 28.88% | 21.99% | 21.54% | 24.07% | 28.3% | 28.77% | 26.14% | 24.89% |
| Debt / Equity | 1.62x | 0.89x | 0.76x | 1.12x | 0.91x | 0.81x | 0.57x | 0.69x | 0.97x | 0.97x |
| Book Value per Share | 23.88 | 24.58 | 30.53 | 34.99 | 44.88 | 50.67 | 72.55 | 77.92 | 80.11 | 80.00 |
| Tangible BV per Share | 19.32 | 21.75 | 27.85 | 19.28 | 23.52 | 26.91 | 47.61 | 44.33 | 36.89 | 38.98 |
MOH Cash Flow Statement
Molina Healthcare, Inc. (MOH) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 804M | -314M | 427M | 1.89B | 2.12B | 773M | 1.66B | 644M | -535M | -535M |
| Operating CF Growth % | 19.47% | -139.05% | 235.99% | 342.62% | 12.12% | -63.52% | 115.01% | -61.25% | -183.07% | 284.22% |
| Operating CF / Revenue % | 4.04% | -1.66% | 2.54% | 9.73% | 7.63% | 2.42% | 4.88% | 1.58% | -1.18% | -1.19% |
| Net Income | -512M | 707M | 737M | 673M | 659M | 792M | 1.09B | 1.18B | 472M | 188M |
| Depreciation & Amortization | 178M | 127M | 89M | 88M | 131M | 176M | 171M | 186M | 195M | 142M |
| Stock-Based Compensation | 46M | 27M | 39M | 57M | 72M | 103M | 115M | 116M | 47M | 33M |
| Deferred Taxes | -94M | -6M | 10M | -19M | -24M | -66M | -31M | 53M | 43M | -6M |
| Other Non-Cash Items | 597M | 80M | -15M | 27M | 58M | 216M | 2M | 8M | -3M | -183M |
| Working Capital Changes | 589M | -1.25B | -433M | 1.06B | 1.22B | -448M | 314M | -898M | -1.29B | 183M |
| Cash from Investing | -1.07B | 1.14B | -293M | -400M | -1.65B | -790M | -744M | -464M | 312M | 446M |
| Capital Expenditures | -86M | -30M | -57M | -74M | -77M | -91M | -84M | -100M | -101M | -106M |
| Acquisitions | 0 | 190M | 0 | -755M | -129M | -134M | -3M | -344M | -245M | 0 |
| Purchase of Investments | -2.72B | -1.44B | -2.54B | -670M | -2.71B | -1.91B | -1.43B | -1.13B | -751M | -811M |
| Sale/Maturity of Investments | 1.77B | 2.44B | 2.3B | 1.1B | 1.33B | 1.4B | 772M | 1.11B | 1.41B | 1.37B |
| Other Investing | -40M | -18M | -2M | 2M | -63M | -50M | 4M | 1M | 1M | -9M |
| Cash from Financing | 636M | -1.19B | -552M | 217M | -183M | -441M | -58M | -347M | -170M | -337M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -47M | -606M | -128M | -400M | -60M | -1B | -1B | -500M |
| Stock Issued | 19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | -1000K | -1000K | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 1000K |
| Other Financing | -8M | -531M | -485M | -36M | -19M | -41M | 2M | -87M | -8M | -25M |
| Net Change in Cash | 367M▲ 0% | -364M▼ 199.2% | -418M▼ 14.8% | 1.72B▲ 510.3% | 283M▼ 83.5% | -458M▼ 261.8% | 860M▲ 287.8% | -167M▼ 119.4% | -393M▼ 135.3% | 469M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3M |
| Cash at Beginning | 2.82B | 3.29B | 2.93B | 2.51B | 4.22B | 4.51B | 4.05B | 4.91B | 4.74B | 4.35B |
| Cash at End | 3.19B | 2.93B | 2.51B | 4.22B | 4.51B | 4.05B | 4.91B | 4.74B | 4.35B | 5.42B |
| Free Cash Flow | 718M▲ 0% | -344M▼ 147.9% | 370M▲ 207.6% | 1.82B▲ 390.8% | 2.04B▲ 12.4% | 682M▼ 66.6% | 1.58B▲ 131.4% | 544M▼ 65.5% | -636M▼ 216.9% | 251M▲ 0% |
| FCF Growth % | 44.47% | -147.91% | 207.56% | 390.81% | 12.44% | -66.6% | 131.38% | -65.53% | -216.91% | -52.19% |
| FCF Margin % | 3.61% | -1.82% | 2.2% | 9.35% | 7.35% | 2.13% | 4.63% | 1.34% | -1.4% | 0.56% |
| FCF per Share | 12.82 | -5.13 | 5.76 | 30.32 | 34.85 | 11.66 | 27.16 | 9.43 | -12.52 | -12.52 |
MOH Key Ratios
Molina Healthcare, Inc. (MOH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 190.86% | 176.17% | 93.76% | 94.45% | 96.33% | 96.33% | 95.38% | 95.8% | 98.28% | 98.84% |
| Medical Cost Ratio | 90.54% | 86.11% | 85.53% | 86.22% | 88.19% | 87.72% | 87.28% | 88.35% | 91.03% | 90.41% |
| Return on Equity (ROE) | -34.29% | 47.39% | 40.87% | 33.19% | 27.89% | 28.32% | 30.39% | 27.07% | 11.02% | 4.44% |
| Return on Assets (ROA) | -6.43% | 9.05% | 10.57% | 8.25% | 6.06% | 6.46% | 8.02% | 7.73% | 3.03% | 1.18% |
| Equity / Assets | 15.78% | 23.02% | 28.88% | 21.99% | 21.54% | 24.07% | 28.3% | 28.77% | 26.14% | 24.89% |
| Book Value / Share | 23.88 | 24.58 | 30.53 | 34.99 | 44.88 | 50.67 | 72.55 | 77.92 | 80.11 | 80 |
| Debt / Equity | 1.62x | 0.89x | 0.76x | 1.12x | 0.91x | 0.81x | 0.57x | 0.69x | 0.97x | 0.97x |
| Revenue Growth | 12.26% | -4.99% | -10.91% | 15.41% | 42.98% | 15.13% | 6.56% | 19.31% | 11.75% | 7.66% |
MOH SEC Filings & Documents
Molina Healthcare, Inc. (MOH) SEC filings — annual & quarterly reports (10-K, 10-Q)
MOH Frequently Asked Questions
Molina Healthcare, Inc. (MOH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Molina Healthcare, Inc. (MOH) grew revenue by 11.7% over the past year. This is steady growth.
Yes, Molina Healthcare, Inc. (MOH) is profitable, generating $188.0M in net income for fiscal year 2025 (1.0% net margin).
Dividend & Returns
Molina Healthcare, Inc. (MOH) has a return on equity (ROE) of 11.0%. This is reasonable for most industries.
Industry Metrics
Molina Healthcare, Inc. (MOH) has a combined ratio of 98.3%. A ratio below 100% indicates underwriting profitability.
Explore More MOH
Molina Healthcare, Inc. (MOH) financial analysis — history, returns, DCA and operating performance tools
Full MOH Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates